<p>Present invention relates to antibodies acting as antidotes against primary inhibitor of thrombin dabigatran. Said antibodies are applied for by-effect prevention at anticoagulant therapy, and bleeding, as well.</p>
申请公布号
GEP20156341(B)
申请公布日期
2015.08.10
申请号
GE2011AP12836
申请日期
2011.01.20
申请人
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
发明人
VAN RYN, JOANNE;PARK, JOHN EDWARD;HAUEL, NORBERT;KUNZ, ULRICH;LITZENBURGER, TOBIAS;CANADA, KEITH;SINGH, SANJAYA;WATERMAN, ALISA
